AI, In-Home Visits, Medicaid And CenterWell Will Improve Care Delivery

Published
06 Aug 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$291.00
3.1% undervalued intrinsic discount
14 Aug
US$281.99
Loading
1Y
-20.9%
7D
9.9%

Author's Valuation

US$291.0

3.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 6.98%

Shared on30 Apr 25
Fair value Decreased 0.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 3.21%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.18%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.18%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 1.05%

AnalystConsensusTarget has increased revenue growth from 2.9% to 5.1%.